Skip to main content
Livermore
Livermore
ZHEN

Meyer Handelman Co

SEC CIK
0000045319
Latest filing
Aug 3, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Meyer Handelman Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
2,609
Value
$1.63M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by Meyer Handelman Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,609$1.63M<0.1%+28+1.1%AddedHolders
Q1 20262,581$1.99M0.1%−297−10.3%ReducedHolders
Q4 20252,878$2.22M0.1%+18+0.6%AddedHolders
Q3 20252,860$1.61M0.1%−612−17.6%ReducedHolders
Q2 20253,472$1.82M0.1%−522−13.1%ReducedHolders
Q1 20253,994$2.53M0.1%−125−3.0%ReducedHolders
Q4 20244,119$2.93M0.1%−141−3.3%ReducedHolders
Q3 20244,260$4.48M0.2%−5−0.1%ReducedHolders
Q2 20244,265$4.48M0.2%00.0%UnchangedHolders
Q1 20244,265$4.11M0.1%00.0%UnchangedHolders
Q4 20234,265$3.75M0.1%+30+0.7%AddedHolders
Q3 20234,235$3.49M0.1%+435+11.4%AddedHolders
Q2 20233,800$2.73M0.1%+225+6.3%AddedHolders
Q1 20233,575$2.94M0.1%+70+2.0%AddedHolders
Q4 20223,505$2.53M0.1%−150−4.1%ReducedHolders
Q3 20223,655$2.52M0.1%+50+1.4%AddedHolders
Q2 20223,605$2.13M0.1%00.0%UnchangedHolders
Q1 20223,605$2.52M0.1%+460+14.6%AddedHolders
Q4 20213,145$1.99M0.1%+175+5.9%AddedHolders
Q3 20212,970$1.80M0.1%00.0%UnchangedHolders
Q2 20212,970$1.66M0.1%+725+32.3%AddedHolders
Q1 20212,245$1.06M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.